Statistic’s Canada outlines the economic impact of the Canadian research and development pharmaceutical sector.
Our resource hub to discover reports, policy papers and other forms of informative content
StatsCan examines the economic footprint made by Canada’s research and development pharmaceutical sector in 2018, including the contributions of Innovative Medicines Canada.
The COVID-19 pandemic has graphically demonstrated the need for a better life sciences environment in Canada. This document outlines the industry’s recommendations for building a thriving sector.